Volume 17, Number 10—October 2011
Research
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010
Laurence Calatayud
, Angie Lackenby, Arlene Reynolds, Jim McMenamin, Nick F. Phin, Maria Zambon, and Richard Pebody
, Angie Lackenby, Arlene Reynolds, Jim McMenamin, Nick F. Phin, Maria Zambon, and Richard PebodyTable 2
Type of immunosuppression, presence of hematopoietic cell transplant, and outcomes for patients with oseltamivir-resistant pandemic (H1N1) 2009, England and Scotland, April 2009–April 30, 2010*
| Type of immunosuppression | No. with oseltamivir-resistant strains | No. with hematopoietic cell transplant | No. admitted to ICU | No. deaths |
|---|---|---|---|---|
| Leukemia | ||||
| Acute lymphocytic | 2 | 1 | ||
| Acute myeloid | 3 | 2 | 1 | 1 |
| Chronic lymphocytic | 5 | 2 | 2 | 2 |
| No precision | 1 | |||
| Lymphoma | ||||
| Non-Hodgkin | 2 | 1 | 1 | 1 |
| Marginal zone | 1 | |||
| Mantle cell | 2 | 1 | ||
| Multiple myeloma | 1 | 1 | 1 | |
| Aplastic anemia | 1 | 1 | ||
| Hematologic cancer with no precision | 1 | 1 | ||
| TRAPS | 1 | |||
| HIV | 1 | 1 | ||
| Total | 21 | 8 | 5 | 7
*ICU, intensive care unit; TRAPS, tumor necrosis factor receptor–associated periodic syndrome. |
*ICU, intensive care unit; TRAPS, tumor necrosis factor receptor–associated periodic syndrome.
